Recognition highlights investment firm’s mission-driven culture and employees’ continued connection with its purpose

Boston, US, 20 May 2025 – Novo Holdings, a leading life science investor, today announced that its Boston office has been named a 2025 Best Place to Work by the Boston Business Journal—its second consecutive year receiving this recognition. In an employee-led survey, Novo Holdings stood out for fostering a sense of purpose and belonging through its mission-driven culture, collaborative workplace, and comprehensive employee benefits package.

The Best Places to Work program, run annually by the Boston Business Journal, honors companies in the Boston area that prioritise employee satisfaction, wellbeing, and professional growth. Employees were asked to rate their work environment, work-life balance, job satisfaction, advancement opportunities, management, compensation, and benefits. Companies must achieve upwards of 90% survey engagement to be a candidate for the award.

Kasim Kutay, Chief Executive Officer, Novo Holdings, commented: “Recognition like this is meaningful because it reflects the voices of our employees. At Novo Holdings, we strive to foster a culture that is rooted in shared values and aligned with our purpose of benefiting people and the planet through responsible investing. This award is a testament to the strength of that culture and the dedication of our team to our mission.”

Ray Camahort, Partner, Venture Investments, Novo Holdings, said: “Having begun my investing career as an associate with Novo Holdings in the Boston office 10 years ago, I have seen firsthand the firm’s commitment to fostering a high-performing, collaborative and respectful culture that prioritises both individual and collective growth. Our connection to the Novo Nordisk Foundation gives our work a clear sense of purpose—knowing our efforts help fund groundbreaking research and drive meaningful change in global health and sustainability.”

Jennifer Adleman, Director, Head of People & Organisation US, added: “Collaboration, respect and a commitment to employee well-being are essential pillars of our workplace and embody the values of our Danish roots. We're honored to be recognised for the second year in a row for our commitment to nurturing a purpose-driven work environment that supports the holistic well-being and growth of all our employees.”

About Novo Holdings A/S
Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk and Novonesis and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Planetary Health Investments and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development. As of year-end 2024, Novo Holdings had total assets of EUR 142 billion.

About the Novo Nordisk Foundation
Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people’s health and the sustainability of society and the planet. The Foundation’s mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.